Major depressive disorder secondary prevention: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Major depressive disorder}} | {{Major depressive disorder}} | ||
{{CMG}} {{Mitra}} | {{CMG}} {{AE}} {{Mitra}} | ||
==Overview== | ==Overview== | ||
Revision as of 10:36, 25 May 2021
|
Major depressive disorder Microchapters |
|
Differentiating Major depressive disorder from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Follow-up |
|
Case Studies |
|
Major depressive disorder secondary prevention On the Web |
|
American Roentgen Ray Society Images of Major depressive disorder secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mitra Chitsazan, M.D.[2]
Overview
Effective measures for the secondary prevention of major depressive disorder include antidepressant maintenance therapy and psychotherapy therapy,
Secondary Prevention
Effective measures for the secondary prevention of major depressive disorder include maintenance pharmacologic therapy with antidepressants and psychotherapy (in particular cognitive behavioral therapy). [1]
References
- ↑ Boland, Robert (2022). Kaplan & Sadock's synopsis of psychiatry. Philadelphia: Wolters Kluwer. ISBN 1975145569.